Company intelligence / Profile preview

ESP Life Sciences Consulting

Ownership: Private
Development stage: Other

Overview

ESP Life Sciences Consulting AB offers expert consultancy in pharmaceutical project and line management within life sciences. The founder brings over 17 years of industry experience leading drug projects through preclinical to Phase II clinical testing for gastrointestinal and cardiovascular disorders. Services include scientific due diligence, experimental design for preclinical/early clinical studies, asset evaluation for larger corporations or investors, grant application support, research group line management assistance within life sciences organizations.[2]

Therapeutic areas: GastroenterologyCardiovascularImmunology
Modalities: Small moleculeBiologic
Industry: Consulting

Beyond the preview

Go deeper on ESP Life Sciences Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESP Life Sciences Consulting.

Explore the full profile